OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production in Chinese hamster ovary (CHO) cells remains a paramount challenge with the biopharmaceutical industry. A variety of strategies are employed maximize antibody titer, comprising process parameter optimization, genetic engineering, and adoption of perfusion processes. Fine-tuning culture condition